The Food and Drug Administration asked states on Tuesday to temporarily halt using Johnson & Johnson’s Covid-19 vaccine “out of an abundance of caution” after six women in the U.S. developed a rare blood-clotting disorder. CNBC's Jim Cramer weighs in on how he expects this development to affect the vaccine distribution process, the markets, reopenings and more.